115 related articles for article (PubMed ID: 9737359)
1. Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study.
Ljunggren JG; Törring O; Wallin G; Taube A; Tallstedt L; Hamberger B; Lundell G
Thyroid; 1998 Aug; 8(8):653-9. PubMed ID: 9737359
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine therapy versus antithyroid medications for Graves' disease.
Ma C; Xie J; Wang H; Li J; Chen S
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
4. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
[TBL] [Abstract][Full Text] [Related]
5. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery.
Abraham-Nordling M; Törring O; Hamberger B; Lundell G; Tallstedt L; Calissendorff J; Wallin G
Thyroid; 2005 Nov; 15(11):1279-86. PubMed ID: 16356093
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves' disease.
Donovan PJ; McLeod DS; Little R; Gordon L
Eur J Endocrinol; 2016 Dec; 175(6):595-603. PubMed ID: 27634939
[TBL] [Abstract][Full Text] [Related]
8. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
[TBL] [Abstract][Full Text] [Related]
9. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
11. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for Graves disease: a cost-effectiveness analysis.
In H; Pearce EN; Wong AK; Burgess JF; McAneny DB; Rosen JE
J Am Coll Surg; 2009 Aug; 209(2):170-179.e1-2. PubMed ID: 19632593
[TBL] [Abstract][Full Text] [Related]
13. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
14. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
15. [Clinical treatment with anti-thyroid drugs or iodine-131 therapy to control the hyperthyroidism of graves disease: a cost-effectiveness analysis].
Cruz Júnior AF; Takahashi MH; Albino CC
Arq Bras Endocrinol Metabol; 2006 Dec; 50(6):1096-101. PubMed ID: 17221117
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
Reinwein D; Benker G; Lazarus JH; Alexander WD
J Clin Endocrinol Metab; 1993 Jun; 76(6):1516-21. PubMed ID: 8501160
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease in children and adolescents: response to long-term treatment.
Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
[TBL] [Abstract][Full Text] [Related]
18. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine treatment, ablation, and ophthalmopathy: a balanced perspective.
Tallstedt L; Lundell G
Thyroid; 1997 Apr; 7(2):241-5. PubMed ID: 9133694
[TBL] [Abstract][Full Text] [Related]
20. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole.
Gumà M; Salinas I; Reverter JL; Roca J; Valls-Roc M; Juan M; Olivé A
J Clin Endocrinol Metab; 2003 May; 88(5):2141-6. PubMed ID: 12727967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
